Development of pituitary dysfunction and destructive thyroiditis is associated with better survival in non-small cell lung cancer patients treated with programmed cell death-1 inhibitors: a prospective study with immortal time bias correction.

Saved in:
Bibliographic Details
Title: Development of pituitary dysfunction and destructive thyroiditis is associated with better survival in non-small cell lung cancer patients treated with programmed cell death-1 inhibitors: a prospective study with immortal time bias correction.
Authors: Suzuki K; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kobayashi T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Izuchi T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Otake K; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ando M; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan., Handa T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Miyata T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Sugiyama M; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Onoue T; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Hagiwara D; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Suga H; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Banno R; Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan., Hase T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Inoue M; Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan., Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Arima H; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan., Iwama S; Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Nov 07; Vol. 15, pp. 1490042. Date of Electronic Publication: 2024 Nov 07 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2392
DOI:10.3389/fendo.2024.1490042